<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The use of extracorporeal assist devices in <z:hpo ids='HP_0001635'>heart failure</z:hpo> is associated with the risk of thromboembolic complications [1] </plain></SENT>
<SENT sid="1" pm="."><plain>Prove of thromboembolic material in the ventricles and tubes of the assist devices is difficult, and the clinical relevance of thrombotic material in the tubes is not clear </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we report on a patient with severe <z:hpo ids='HP_0001635'>heart failure</z:hpo> caused by endstage <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> who was bridged to transplantation using a biventricular assist device (BVAD) </plain></SENT>
<SENT sid="3" pm="."><plain>Five weeks after implantation, transcranial Doppler sonography (TCD) revealed high intensity transient signals (HITS) in basal cerebral arteries, suggesting continued cerebral microembolism </plain></SENT>
<SENT sid="4" pm="."><plain>Apart from a correlation of these Doppler sonographic findings with neurological symptoms, macroscopic evidence of fibrin <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> in the artificial ventricle, and post mortem confirmation of <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> could be proved </plain></SENT>
</text></document>